User menu

Search for monoglyceride lipase inhibitors : synthesis and screening of arylthioamides derivatives

Bibliographic reference Kapanda Nankwa, Coco ; Muccioli, Giulio ; Labar, Geoffray ; Draoui, Nihed ; Lambert, Didier ; et. al. Search for monoglyceride lipase inhibitors : synthesis and screening of arylthioamides derivatives. In: Medicinal Chemistry Research, Vol. 18, no. 4, p. 243-254 (2009)
Permanent URL
  1. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996) Molecular Characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384:83–87. doi: 10.1038/384083a0
  2. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946–1949. doi: 10.1126/science.1470919
  3. Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC et al (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372:686–691. doi: 10.1038/372686a0
  4. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99:10819–10824. doi: 10.1073/pnas.152334899
  5. Deutsch DG, Omeir R, Arreaza G (1997) Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol 53:255–260. doi: 10.1016/S0006-2952(96)00830-1
  6. Facci L, Dal Toso R, Romanello S, Buriani A, Skaper SD, Leon A (1995) Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci USA 92:3376–3380. doi: 10.1073/pnas.92.8.3376
  7. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P et al (1995) Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232:54–61. doi: 10.1111/j.1432-1033.1995.tb20780.x
  8. Hashimotodani Y, Ohno-Shosaku T, Kano M (2007) Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabiboid signalling in hippocampus. J Neurosci 27(5):1211–1219. doi: 10.1523/JNEUROSCI.4159-06.2007
  9. Hillard CJ, Edgemont WS, Jarrahian A, Campbell WB (1997) Accumulation of N- arachidonoylethanolamide (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69:631–638
  10. Ishac Edward J.N., Jiang Liu, Lake Kristy D., Varga Karoly, Abood Mary E., Kunos George, Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves, 10.1111/j.1476-5381.1996.tb15639.x
  11. Jayamanne A, Greenwood R, Mitchell VA, Aslan S, Piomelli D, Vaughan CW (2006) Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models. Br J Pharmacol 147(3):281–288. doi: 10.1038/sj.bjp.0706510
  12. Kathuria DG, Gaetani S, Flegey D (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9:76–81. doi: 10.1038/nm803
  13. Kishimoto S, Kobayashi Y, Oka S, Gokoh M, Waku K, Sugiura T (2004) 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, induces accelerated production of chemokines in HL–60 cells. J Biochem 135(4):517–524. doi: 10.1093/jb/mvh063
  14. Labar G, Michaux C (2007) Fatty acid amide hydrolase: from characterization to Therapeutics. Chem Biodivers 4:1882–1902. doi: 10.1002/cbdv.200790157
  15. Labar G, Bauvois C, Muccioli GG, Wouters J, Lambert DM (2007) Disulfiram is an inhibitor of purified monoacylglycerollipase, the enzyme regulating 2-arachidonoylglycerol signalling. ChemBioChem 8:1293–1297. doi: 10.1002/cbic.200700139
  16. Labar G, Vliet FV, Wouters J, Lambert DM (2008) A MBP-FAAH fusion protein as a tool to produce human and rat fatty acid amide hydrolase: expression and pharmacological comparison. Amino Acids 34:127–133. doi: 10.1007/s00726-007-0540-1
  17. Lambert DM, Fowler CJ (2005) The endocannabinoid system: drugs targets, lead compounds, and potential therapeutic applications. J Med Chem 48(16):5059–5087. doi: 10.1021/jm058183t
  18. Makara JK, Mor M, Flegey D (2005) Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signalling in hippocampus. Nat Neurosci 8:1139–1141. doi: 10.1038/nn1521
  19. Mechoulam R (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50:83–90. doi: 10.1016/0006-2952(95)00109-D
  20. Moore SA, Nomikos GG, Dickason-Chesterfield AK, Schober DA, Schaus JM, Ying B-P, XU Y-C, Phebus L, Simmons RMA, Li D, Iyengar S, Felder CC (2005) Identification of a high-affinity binding site involved in the transport of endocannabinoids. Proc Natl Acad Sci USA 102:17852–17857. doi: 10.1073/pnas.0507470102
  21. Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM et al (2007) Identification of a novel endocannabinoid–hydrolyzing enzyme expressed by microglial cells. J Neurosci 27:2883–2889. doi: 10.1523/JNEUROSCI.4830-06.2007
  22. Pacher P, Bátkai S, Kunos G (2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58:389–462. doi: 10.1124/pr.58.3.2
  23. Poupaert JH, Duarte S, Colacino E, Depreux P, McCurdy CR, Lambert DM (2004) Willgerodt–Kindler microwave-enhanced synthesis of thioamides derivatives. Phos Sulf Sil Rel. Elem 179:1959–1973
  24. Poupaert JH, Carato P, McCurdy CR (2005) A simple and effective method for the thionation of amides to thioamides by using Al2O3-supported P4S10. Lett Org Chem 2:330–333. doi: 10.2174/1570178054038957
  25. Rolfs A, Liebscher J (1998) 3-morpholino-2-phenylthioacrylic acid morpholide and 5-(4-bromobenzoyl-2-(4-morpholino)-3-phenylthiophene. Org Synth Coll 9:99
  26. Saario SM, Laitinen JT (2007) Monoglyceride lipase as an enzyme hydrolyzing 2-arachidonoylglycerol. Chem Biodivers 4(8):1903–1913. doi: 10.1002/cbdv.200790158
  27. Saario SM, Poso A, Juvonen RO, Järvinen T, Salo-Ahen OM (2006) Fatty Acid Amid Hydrolase inhibitors from virtual screening of the endocannabinoid system. J Med Chem 49:4650–4656. doi: 10.1021/jm060394q
  28. Saario SM, Salo OM, Nevalainen T, Poso A, Laitinen JT, Järvinen T et al (2005) Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysisi of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol 12:649–656. doi: 10.1016/j.chembiol.2005.04.013
  29. Sagan S, Vanance L, Torrens Y, Cordier J, Glowinski J, Giaume C (1999) Anandamide and WIN 55212–2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes. Eur J Neurosci 11:691–699. doi: 10.1046/j.1460-9568.1999.00480.x
  30. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K et al (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brainBiochem. Biophys Res Commun 215:89–905. doi: 10.1006/bbrc.1995.2437
  31. Tarzia G, Antonietti F, Duranti A, Tontini A, Mor M, Rivara S, Traldi P, Astarita G, King A, Clapper JR, Piomelli D (2007) Identification of a bioactive impurity in a commercial sample of 6-methyl-2-p-tolylaminobenzo[d][1,3] oxazin-4-one (URB754). Ann di Chim 97:887–894
  32. Vandevoorde S, Jonsson KO, Labar G, Persson E, Lambert DM, Fowler CJ (2007) Lack of selectivity of URB602 for 2-oleoylglycerol compared to Anandamide hydrolysis in vitro. Br J Pharmacol 150:186–191. doi: 10.1038/sj.bjp.0706971
  33. Wilson RI, Nicoll RA (2001) Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410:588–592. doi: 10.1038/35069076